Clover Health Investments, Corp. (NASDAQ:CLOV) Q4 2022 Earnings Conference Call February 28, 2023 8:30 AM ET Company Participants Ryan Schmidt - Investor Relations Andrew Toy - CEO Scott J. Leffler - CFO Conference Call Participants William Hoover - Canaccord Genuity Benjamin Rossi - Citigroup Kevin Fischbeck - Bank of America Operator Good morning ladies and gentlemen and welcome to the Clover Health Fourth Quarter and Full Year 2022 Earnings Conference Call. At this time, all participants are in a listen- ...

Clover Health Fourth Quarter and Full Year 2022 - Earnings Results Disclaimer This presentation and the accompanying oral presentation include forward-looking statements, including statements regarding future events and Clover Health Investments, Corp.'s ("Clover Health," "we," "our," or "us") future results of operations, financial condition, outlook, market size and opportunity, business strategy and plans, and the factors affecting our performance and our objectives for future operations. These forward-l ...

Clover Health J.P. Morgan Healthcare Conference January 11, 2023 Disclaimer This presentation and the accompanying oral presentation include forward-looking statements, including statements regarding future events and Clover Health Investments, Corp.'s ("Clover," "we," "our," or "us") future results of operations, financial position, business strategy and future plans, and the factors affecting our performance and our objectives for future operations. These forward-looking statements are subject to a number ...

Clover Health Investments, Corp. (NASDAQ:CLOV) Q3 2022 Earnings Conference Call November 7, 2022 5:00 PM ET Company Participants Ryan Schmidt - Investor Relations Vivek Garipalli - Chief Executive Officer Andrew Toy - President Scott Leffler - Chief Financial Officer Conference Call Participants Jason Cassorla - Citi Richard Close - Canaccord Genuity Kevin Fischbeck - Bank of America Whit Mayo - SVB Securities. Operator Please stand-by, your program is about to begin. Ladies and gentlemen, good afternoon, a ...

Clover Health Third Quarter 2022 - Earnings Results Clover Health Disclaimer This presentation and the accompanying oral presentations include forward-looking statements, including statements regarding future events and Clover Health Investments, Corp.'s ("Clover," "we," "our," or "us") future results of operations, financial position, market size and opportunity, business strategy and plans, and the factors affecting our performance and our objectives for future operations. These forward-looking statements ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ________________________________________ FORM 10-Q ________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 1 For the quarterly period ended September 30, 2022 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission File Number: 001-39252 _________________ ...

Clover Health Investments Corp (NASDAQ:CLOV) Q2 2022 Earnings Conference Call August 8, 2022 5:00 PM ET Company Participants Ryan Schmidt - IR Vivek Garipalli - Co-Founder, CEO & Chairman Andrew Toy - Co-Founder, President, & Director Mark Herbers - Principal Accounting Officer Conference Call Participants Richard Close - Canaccord Genuity Kevin Fischbeck - Bank of America Merrill Lynch Jason Cassorla - Citigroup Benjamin Mayo - SVB Securities Gary Taylor - Cowen and Company Operator Ladies and gentlemen, g ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ________________________________________ ________________________________________ FORM 10-Q ________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ | --- | --- | |-- ...

Clover Health Investments, Corp. (NASDAQ:CLOV) Q1 2022 Results Conference Call May 9, 2022 5:00 PM ET Company Participants Derrick Nueman - Head or Investor Relations and Corporate Strategy Vivek Garipalli - CEO Andrew Toy - President Mark Herbers - Interim CFO Conference Call Participants Richard Close - Canaccord Genuity Jason Cassorla - Citi Whit Mayo - SVB Securities Kevin Fischbeck - Bank of America Operator Ladies and gentlemen, good day and welcome to the Clover Health First Quarter 2022 Earnings Con ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ________________________________________ ________________________________________ FORM 10-Q ________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ | --- | --- | |- ...